Neola Medical AB (publ) (STO:NEOLA)

Neola Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	87	83	142	109	28	55
Market Cap Growth	-58.52%	-41.69%	30.50%	282.12%	-48.28%	-3.33%
Enterprise Value	71	61	118	82	20	50
Last Close Price	1.12	1.06	2.02	1.95	1.35	2.58
PS Ratio	10.54	9.98	14.01	11.05	2.92	4.94
PB Ratio	1.15	1.09	2.06	1.37	0.42	1.35
P/TBV Ratio	1.15	1.09	2.06	1.37	0.42	1.35
EV/Sales Ratio	8.59	7.31	11.62	8.34	2.07	4.53
Net Debt / Equity Ratio	-0.21	-0.21	-0.28	-0.27	-0.59	-0.56
Net Debt / EBITDA Ratio	1.66	1.66	2.08	2.63	4.20	3.46
Net Debt / FCF Ratio	1.35	1.35	1.79	3.30	4.66	3.23
Asset Turnover	0.11	0.11	0.13	0.12	0.16	0.32
Quick Ratio	5.75	5.75	4.43	6.90	7.69	7.64
Current Ratio	5.75	5.75	4.53	7.00	7.78	7.76
Return on Equity (ROE)	-15.23%	-15.23%	-13.60%	-12.30%	-19.15%	-20.73%
Return on Assets (ROA)	-9.10%	-9.10%	-8.46%	-7.46%	-10.62%	-11.92%
Return on Capital Employed (ROCE)	-14.60%	-14.60%	-15.70%	-12.10%	-14.50%	-16.40%
Earnings Yield	-12.62%	-13.34%	-7.10%	-8.30%	-36.43%	-12.11%
FCF Yield	-	-14.46%	-7.70%	-6.02%	-30.26%	-12.93%
Buyback Yield / Dilution	-9.27%	-9.27%	-25.80%	-113.90%	-86.03%	-48.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.